BGM Group Ltd. (BGM)
Nasdaq: BGM · Pharmaceutical Preparations · Chengdu, CN · filing with the SEC since 2019
Who runs BGM Group Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedOfficers reporting now
1
of 5 people with a filing in the last fifteen months
Directors reporting now
4
5 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Zhai Yaxuan | Chief Financial Officer | May 2026 | May 14, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Lou Zefei | director | May 2026 | May 14, 2026 | none |
| Ren Yuehua | director | May 2026 | May 14, 2026 | none |
| Xu Waihua | director | May 2026 | May 14, 2026 | none |
| Zhang Lin (Henry) | director | Apr 2026 | Apr 13, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.